| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327515 | Gynecologic Oncology | 2005 | 4 Pages |
Abstract
Single-agent paclitaxel consolidation therapy can be administered for 12 cycles following first-line carboplatin, paclitaxel, and gemcitabine induction therapy, but there is considerable risk for development of a moderately severe peripheral neuropathy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
John P. Micha, Bram H. Goldstein, Julie A. Mattison, Kathy Bader, Cheri Graham, Mark A. Rettenmaier, John V. Brown, Maurie Markman,